AC
BIIB icon

Avestar Capital’s Biogen BIIB Stock Holding History

Avestar Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$211K – 298
2022
Q1 		$211K Sell
1,000
-1,500
-60% -$326K 0.03% 367
2021
Q4 		$600K Buy
+2,500
New +$643K 0.07% 226
2021
Q3 		– Sell
-3,200
Closed -$1.11M – 451
2021
Q2 		$1.11M Buy
+3,200
New +$969K 0.15% 168

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Avestar Capital's BIIB Position: Q1 2026 in Review

Avestar Capital increased its Biogen (BIIB) stake by 2% in Q1 2026, buying an estimated $12.7K and bringing the position to 3,604 shares worth $661K. The position accounts for 0.04% of the portfolio, ranked #294.

Avestar Capital first reported a position in BIIB in Q4 2017 and has held it in 34 quarters since. The position peaked at $852K in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Avestar Capital held 3,604 shares of Biogen worth $661K as of Q1 2026.
  • Avestar Capital bought 69 Biogen shares in Q1 2026, an estimated $12.7K.
  • Biogen made up 0.04% of Avestar Capital's portfolio in Q1 2026, its #294 holding.
  • Avestar Capital first reported a position in Biogen in Q4 2017 and has held it in 34 quarters since.
  • Avestar Capital's Biogen position peaked at $852K in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.